Probucol Release from Novel Multicompartmental Microcapsules for the Oral Targeted Delivery in Type 2 Diabetes

In previous studies, we developed and characterised multicompartmental microcapsules as a platform for the targeted oral delivery of lipophilic drugs in type 2 diabetes (T2D). We also designed a new microencapsulated formulation of probucol-sodium alginate (PB-SA), with good structural properties an...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:AAPS PharmSciTech
Main Authors: Mooranian, Armin, Negrulj, Rebecca, Al-Sallami, Hesham S., Fang, Zhongxiang, Mikov, Momir, Golocorbin-Kon, Svetlana, Fakhoury, Marc, Watts, Gerald F., Matthews, Vance, Arfuso, Frank, Lambros, Amanda, Al-Salami, Hani
Formato: Artigo
Idioma:Inglês
Publicado: Springer US 2014
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4309805/
https://ncbi.nlm.nih.gov/pubmed/25168450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12249-014-0205-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares